Vaxcyte
PCVX
PCVX
125 hedge funds and large institutions have $1.45B invested in Vaxcyte in 2022 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 50 increasing their positions, 27 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
14.66% more ownership
Funds ownership: 88.21% → 102.87% (+15%)
38% less funds holding in top 10
Funds holding in top 10: 8 → 5 (-3)
42% less call options, than puts
Call options by funds: $7.95M | Put options by funds: $13.6M
Holders
125
Holding in Top 10
5
Calls
$7.95M
Puts
$13.6M
Top Buyers
| 1 | +$116M | |
| 2 | +$38.9M | |
| 3 | +$21.3M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$15.1M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$12.7M |
Top Sellers
| 1 | -$9.24M | |
| 2 | -$9.17M | |
| 3 | -$6.48M | |
| 4 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$5.76M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$4.92M |